Anticonvulsant Drugs and Chronic Pain

Swerdlow, Mark

doi:10.1097/00002826-198403000-00003

Cited by 181 publications

(39 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Paroxetine and fluoxetine have opposite effects 36 . Carbamazepine accelerates methadone's metabolism, while gabapentine and valproic acid do not modify it 37 . Methadone is safe and effective for treating cancer-related pain 38,39 .…”

Section: The Role Of Methadone In Non-malignant Chronic Painmentioning

confidence: 97%

See 1 more Smart Citation

O uso de opióides no tratamento da dor crônica não oncológica: o papel da metadona

Ribeiro

Schmidt²,

Schmidt³

2002

Rev. Bras. Anestesiol.

View full text Add to dashboard Cite

show abstract

Section: The Role Of Methadone In Non-malignant Chronic Painmentioning

confidence: 97%

“…Paroxetina e fluoxetina têm efeito contrário 36 . Carbamazepina acelera o metabolismo da metadona, enquanto gabapentina e ácido valpróico não o modificam 37 . A metadona é uma droga com eficácia e segurança comprovadas para tratamento de síndromes dolorosas relacionadas ao câncer 38,39 .…”

Section: Conclusion -Although the Growing Knowledge On The Use Of Opunclassified

O uso de opióides no tratamento da dor crônica não oncológica: o papel da metadona

Ribeiro

Schmidt²,

Schmidt³

2002

Rev. Bras. Anestesiol.

View full text Add to dashboard Cite

show abstract

“…Although a mainstay for treatment of trigeminal neuralgia, 115,116 and also used for the treatment of glossopharyngeal neuralgia 117 and other paroxysmal pain, 118 no RCTs have been identified which specifically examined the effect of this drug in patients with MS. Trials of its use in idiopathic trigeminal neuralgia have demonstrated clear superiority over placebo, and effectiveness in relieving pain in 70-84% of cases.…”

Section: Specific Drug Treatments Carbamazepinementioning

confidence: 99%

“…Reviews 115,116 suggest that it is not as consistently effective at suppressing (idiopathic) trigeminal neuralgia as is carbamazepine. There are case reports suggesting that it is effective in the treatment of painful tonic seizures 120 and non-specific limb pain.…”

Section: Phenytoinmentioning

confidence: 99%

Treatments for spasticity and pain in multiple sclerosis: a systematic review

Beard

Hunn²,

Wight³

2003

Health Technol Assess

235

131

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents, York Publishing Services by:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS and public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please contact York Publishing Services at the address above. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to York Publishing Distribution and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.ncchta.org/htacd.htm). Or contact York Publishing Services (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTATreatments for spasticity and pain in multiple sclerosis: a systematic review NHS R&D HTA ProgrammeT he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS.The research reported in this monograph was commissioned by the HTA Programme and funded as project number 99/05/03. Technology assessment reports are completed in a limited time to inform decisions in key areas by bringing together evidence on the use of the technology concerned.The views expressed in this publication are those of the authors and not necessarily those of the HTA Programme or the Department of Health. The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for any recommendations made by the authors. HTA Programme Director:Professor Kent Woods Series Editors:Professor Andrew Stevens, Dr Ken Stein, Professor John Gabbay, Dr Ruairidh Milne, Dr Chris Hyde and Dr Rob Riemsma Managing Editors:Sally Bailey and ...

show abstract

“…These two painful neurological condi tions were chosen not only for their chronic nature, but because of similar reported analgesic response to the anticonvulsants phenytoin and carbamazepine [17,18).…”

Section: Introductionmentioning

confidence: 99%

Baclofen as an Analgesic in Chronic Peripheral Nerve Disease

1985

View full text Add to dashboard Cite

Baclofen has shown analgesic properties in a number of animal studies but has failed as a conventional analgesic in the human postoperative dental pain model. In order to test baclofen’s analgesic properties in more chronic pain conditions, we selected postherpetic neuralgia and diabetic neuropathy pain as possible trial diseases for baclofen analgesia. 15 patients with postherpetic neuralgia and 10 with diabetic neuropathy pain were treated with baclofen. In the spinal postherpetic neuralgia group and diabetic neuropathy group, there was little evidence of analgesic effect. 6 of 7 patients with facial postherpetic neuralgia had a good response to baclofen during the 3-week trial. Baclofen does not appear to be a conventional analgesic.

show abstract

Anticonvulsant Drugs and Chronic Pain

Cited by 181 publications

References 0 publications

O uso de opióides no tratamento da dor crônica não oncológica: o papel da metadona

O uso de opióides no tratamento da dor crônica não oncológica: o papel da metadona

Treatments for spasticity and pain in multiple sclerosis: a systematic review

Baclofen as an Analgesic in Chronic Peripheral Nerve Disease

Contact Info

Product

Resources

About